These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 12384565

  • 1. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF, Gottenger E, Nguyen C, Song W, Kattan MW, Andenoro J, Wheeler TM, Spencer DM, Slawin KM.
    Cancer Res; 2002 Oct 15; 62(20):5974-9. PubMed ID: 12384565
    [Abstract] [Full Text] [Related]

  • 2. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler TM, Slawin KM.
    Cancer Res; 2003 Sep 15; 63(18):5874-8. PubMed ID: 14522912
    [Abstract] [Full Text] [Related]

  • 3. Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein.
    Slawin KM, Shariat SF, Nguyen C, Leventis AK, Song W, Kattan MW, Young CY, Tindall DJ, Wheeler TM.
    Cancer Res; 2000 Dec 15; 60(24):7142-8. PubMed ID: 11156423
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Detection of micrometastatic prostate cancer cells in the lymph nodes by reverse transcriptase polymerase chain reaction is predictive of biochemical recurrence in pathological stage T2 prostate cancer.
    Okegawa T, Nutahara K, Higashihara E.
    J Urol; 2000 Apr 15; 163(4):1183-8. PubMed ID: 10737491
    [Abstract] [Full Text] [Related]

  • 6. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young CY, Ellis WJ, Vessella RL.
    Urology; 1997 Aug 15; 50(2):184-8. PubMed ID: 9255285
    [Abstract] [Full Text] [Related]

  • 7. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.
    Gao CL, Dean RC, Pinto A, Mooneyhan R, Connelly RR, McLeod DG, Srivastava S, Moul JW.
    J Urol; 1999 Apr 15; 161(4):1070-6. PubMed ID: 10081840
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [RT-PCR assay for detecting PSA mRNA in peripheral blood of prostate cancer patients].
    Okubo Y, Ito T.
    Hinyokika Kiyo; 1999 Jan 15; 45(1):25-30. PubMed ID: 10086262
    [Abstract] [Full Text] [Related]

  • 11. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
    Haese A, Vaisanen V, Lilja H, Kattan MW, Rittenhouse HG, Pettersson K, Chan DW, Huland H, Sokoll LJ, Partin AW.
    J Urol; 2005 Mar 15; 173(3):752-6. PubMed ID: 15711262
    [Abstract] [Full Text] [Related]

  • 12. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
    Stephan C, Jung K, Nakamura T, Yousef GM, Kristiansen G, Diamandis EP.
    Int J Urol; 2006 Mar 15; 13(3):238-43. PubMed ID: 16643616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG, Raj GV, Moreno JG.
    J Urol; 1997 Aug 15; 158(2):326-37. PubMed ID: 9224297
    [Abstract] [Full Text] [Related]

  • 15. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T, Schalken J, Wittjes W, Ljungberg B, Lilja H.
    Prostate; 2001 Apr 15; 47(1):14-20. PubMed ID: 11304725
    [Abstract] [Full Text] [Related]

  • 16. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L, Ferruelo A, Luján M, Pascual C, García-Mediero JM, Berenguer A.
    Prostate Cancer Prostatic Dis; 2005 Apr 15; 8(3):248-52. PubMed ID: 15897916
    [Abstract] [Full Text] [Related]

  • 17. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
    Freedland SJ, Hotaling JM, Fitzsimons NJ, Presti JC, Kane CJ, Terris MK, Aronson WJ, Amling CL.
    Eur Urol; 2008 Apr 15; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
    [Abstract] [Full Text] [Related]

  • 18. Clinical and molecular followup after radical retropubic prostatectomy.
    Oefelein MG, Ignatoff JM, Clemens JQ, Watkin W, Kaul KL.
    J Urol; 1999 Aug 15; 162(2):307-10; discussion 310-1. PubMed ID: 10411026
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.
    Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Sagalowsky AI, Roehrborn CG, Koeneman KS.
    BJU Int; 2004 Jul 15; 94(1):42-6. PubMed ID: 15217428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.